Preview

South Russian Journal of Cancer

Advanced search

Cellular, genomic and transcriptomic effects of secondary metabolites of the Hybrid Butterbur on the HeLa cell line

https://doi.org/10.37748/2686-9039-2024-5-3-5

EDN: KOUKIT

Abstract

Purpose of the study. To evaluate the cellular, genomic (gene copy number) and transcriptomic (gene expression) effects of P.hybridus (L.) secondary metabolites when they affect the HeLa cell line.

Materials and methods. The isolation of secondary metabolites from plant material and its identification were carried out by preparative chromatography. The composition was determined using mass spectrometric analysis, and the final verification of structural formulas was carried out by nuclear magnetic resonance at the Department of Natural Compounds, the Faculty of Chemistry of the Southern Federal University. The subsequent phase of the study was conducted using both cultural and molecular methods. HeLa cells were cultivated under standard conditions in a MEM medium. Once the confluence level was reached 75–80 %, the nutrient medium was replaced with the introduction of the studied compounds (at a concentration of 4 micrograms/ml) and cultivated for 72 hours. Cell mortality was determined using a NanoEnTek JuliFl counter (Korea) in the presence of 0.4 % trypan blue. The assessment of apoptosis following secondary metabolite exposure was conducted on a BD FACSCanto II flow cytometer using the FITC Annexin V Apoptosis Detection Kit I. The level of replication and expression of the genes responsible for apoptosis was assessed by digital droplet PCR (ddPCR).

Results. The following compounds were isolated and verified, and were assigned the following sequence numbers to facilitate their use in the experiment: No. 2 – 2,4-dihydroxy-2,5-dimethylfuran-3(2H)-one, No. 3 – 5-(hydroxymethyl) furan-2-carbaldehyde, No. 5.3 – 2,2,8-trimethyldecahydroazulene-5,6-dicarbaldehyde, P. hybridus (L.) At the stage of cell death assessment, it was found that the greatest effect was achieved in the compound under ordinal No. 2. However, the evaluation of the copy number and expression of the CASP8, CASP9, CASP3, BAX, BCL2, TP53, MDM2, CDKN1B, CDK1, CCND1, CCND3, and RB1 genes by DD-PCR revealed the presence of apoptosis initiation in tumor cells at the molecular level under the action of compounds No. 2 and No. 5.3 obtained from P. hybridus (L.).

Conclusion. The outcomes were multifeatured. Only compound 2,4-dihydroxy-2,5-dimethylfuran-3(2H)-one exhibited a pronounced cytostatic effect out of all compounds utilized in the experiment. Concurrently, the compound 2,2,8-trimethyldecahydroazulene-5,6-dicarbaldehyde was found to induce an increase in the expression of the CASP3, CASP8, TP53, and BAX genes.

About the Authors

E. Yu. Zlatnik
National Medical Research Centre for Oncology
Russian Federation

Elena Yu. Zlatnik – Dr. Sci. (Med.), MD, Professor, Chief Researcher, Laboratory of Immunophenotyping of Tumors, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

ORCID: https://orcid.org/0000-0002-1410-122X, SPIN: 4137-7410, AuthorID: 327457, ResearcherID: AAI-1311-2020, Scopus Author ID: 6603160432


Competing Interests:

the authors declare that there are no obvious and potential conflicts of interest associated with the publication of this article



Ya. S. Enin
National Medical Research Centre for Oncology
Russian Federation

Yaroslav S. Enin – Junior Researcher, Laboratory of Molecular Oncology, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

ORCID: https://orcid.org/0000-0002-4572-1579, SPIN: 7683-2286, AuthorID: 840050, Scopus Author ID: 57196464479


Competing Interests:

the authors declare that there are no obvious and potential conflicts of interest associated with the publication of this article



O. N. Burov
Southern Federal University
Russian Federation

Oleg N. Burov – Cand. Sci. (Chem.), Associate Professor, Department of Natural and High Molecular Compounds, Faculty of Chemistry, Southern Federal University, Rostov-on-Don, Russian Federation

ORCID: https://orcid.org/0000-0002-7704-033X, SPIN: 5269-7656, AuthorID: 642948, ResearcherID: A-8428-2014, Scopus Author ID: 23033004000


Competing Interests:

the authors declare that there are no obvious and potential conflicts of interest associated with the publication of this article



E. S. Bondarenko
National Medical Research Centre for Oncology
Russian Federation

Elena S. Bondarenko – Junior Researcher, Laboratory of Immunophenotyping of Tumors, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

ORCID: https://orcid.org/0000-0002-8522-1026, SPIN: 3117-4040, AuthorID: 865798, Scopus Author ID: 57200132337


Competing Interests:

the authors declare that there are no obvious and potential conflicts of interest associated with the publication of this article



A. B. Sagakyants
National Medical Research Centre for Oncology
Russian Federation

Alexander B. Sagakyants – Cand. Sci. (Biol.), Head of the Laboratory of Immunophenotyping of Tumors, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

ORCID: https://orcid.org/0000-0003-0874-5261, SPIN: 7272-1408, AuthorID: 426904, ResearcherID: M-8378-2019, Scopus Author ID: 24329773900


Competing Interests:

the authors declare that there are no obvious and potential conflicts of interest associated with the publication of this article



D. S. Kutilin
National Medical Research Centre for Oncology
Russian Federation

Denis S. Kutilin – Cand. Sci. (Biol.), Leading Researcher, Laboratory of Molecular Oncology, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

ORCID: https://orcid.org/0000-0002-8942-3733, SPIN: 8382-4460, AuthorID: 794680, Scopus Author ID: 55328886800


Competing Interests:

the authors declare that there are no obvious and potential conflicts of interest associated with the publication of this article



Yu. V. Dzigunova
Southern Federal University
Russian Federation

Yulia V. Dzigunova – Senior Lecturer, Department of Botany, Academy of Biology and Biotechnology. DI. Ivanovoskogo Southern Federal University, Rostov-on-Don, Russian Federation

SPIN: 2204-2967, AuthorID: 1062681


Competing Interests:

the authors declare that there are no obvious and potential conflicts of interest associated with the publication of this article



I. A. Novikova
National Medical Research Centre for Oncology
Russian Federation

Inna A. Novikova – Dr. Sci. (Med.), MD, deputy director for science, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

ORCID: https://orcid.org/0000-0002-6496-9641, SPIN: 4810-2424, AuthorID: 726229, ResearcherID: E-7710-2018, Scopus Author ID: 7005153343


Competing Interests:

the authors declare that there are no obvious and potential conflicts of interest associated with the publication of this article



Yu. V. Przhedetskiy
National Medical Research Centre for Oncology
Russian Federation

Yury V. Przhedetskiy – Dr. Sci. (Med.), MD, Professor, Head of the Department of Reconstructive Plastic Surgery and Oncology, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation

ORCID: https://orcid.org/0000-0003-3976-0210, SPIN: 3888-6265, ResearcherID: ATT-7598-2020, Scopus Author ID: 57188731912


Competing Interests:

the authors declare that there are no obvious and potential conflicts of interest associated with the publication of this article



References

1. Hegde YM, Theivendren P, Srinivas G, Palanivel M, Shanmugam N, Kunjiappan S, et al. A Recent Advancement in Nanotechnology Approaches for the Treatment of Cervical Cancer. Anticancer Agents Med Chem. 2023;23(1):37–59. https://doi.org/10.2174/1871520622666220513160706

2. Кутилин Д. С., Могушкова Х. А. Влияние противоопухолевых антибиотиков антрациклинового ряда на транскрипционную активность раково-тестикулярных антигенов в модельном эксперименте на клеточной линии HeLa. Медицинская иммунология. 2019;21(3):539–546. https://doi.org/10.15789/1563-0625-2019-3-539-546, EDN: SIWZEN

3. Cox E. Performing HeLa: theatrical bodies and living remains. Med Humanit. 2023 Sep;49(3):447–456. https://doi.org/10.1136/medhum-2022-012524

4. Li Y, Kong D, Fu Y, Sussman MR, Wu H. The effect of developmental and environmental factors on secondary metabolites in medicinal plants. Plant Physiol Biochem. 2020 Mar;148:80–89. https://doi.org/10.1016/j.plaphy.2020.01.006

5. Fakhri S, Moradi SZ, Farzaei MH, Bishayee A. Modulation of dysregulated cancer metabolism by plant secondary metabolites: A mechanistic review. Semin Cancer Biol. 2022 May;80:276–305. https://doi.org/10.1016/j.semcancer.2020.02.007

6. Zagoskina NV, Nazarenko LV. Secondary Plant Metabolites: Distribution, History of Study, Practical Application Bulletin of the Moscow City Pedagogical University. Series "Pedagogy and Psychology". 2019;(2(34)):8–19. https://doi.org/10.25688/2076-9091.2019.34.2.1

7. Mohiuddin AK. Chemistry of Secondary Metabolites. Annals of Clinical Toxicology. 2019 Jan 29;2. http://doi.org/10.25107/2641-905X-v2-id1014

8. Apostolova S, Oreshkova T, Uzunova V, Georgieva I, Maslenkova L, Tzoneva R. A Standardized Extract of Petasites hybridus L., Containing the Active Ingredients Petasins, Acts as a Pro-Oxidant and Triggers Apoptosis through Elevating of NF-κB in a Highly Invasive Human Breast Cancer Cell Line. Front Biosci (Landmark Ed). 2023 Jun 12;28(6):111. https://doi.org/10.31083/j.fbl2806111

9. Matsumoto T, Imahori D, Saito Y, Zhang W, Ohta T, Yoshida T, et al. Cytotoxic activities of sesquiterpenoids from the aerial parts of Petasites japonicus against cancer stem cells. J Nat Med. 2020 Sep;74(4):689–701. https://doi.org/10.1007/s11418-020-01420-x

10. Кутилин Д. С., Кечерюкова М. М. От биоинформационного скрининга генетических маркёров к малоинвазивной диагностике метастазов в лимфатических узлах у пациенток с раком шейки матки. Казанский медицинский журнал. 2022;103(5):725–736. https://doi.org/10.17816/KMJ2022-725, EDN: OTTJXB

11. Тимофеева С. В., Филиппова С. Ю., Ситковская А. О., Гненная Н. В., Межевова И. В., Шамова Т. В. и др. Биоресурсная коллекция клеточных линий и первичных опухолей ФГБУ НМИЦ онкологии Минздрава России. Кардиоваскулярная терапия и профилактика. 2022;21(11):44–50. https://doi.org/10.15829/1728-8800-2022-3397, EDN: MWVYOR

12. Bouabdallah S, Al-Maktoum A, Amin A. Steroidal Saponins: Naturally Occurring Compounds as Inhibitors of the Hallmarks of Cancer. Cancers (Basel). 2023 Jul 31;15(15):3900. https://doi.org/10.3390/cancers15153900

13. Pang J, Vince JE. The role of caspase-8 in inflammatory signalling and pyroptotic cell death. Semin Immunol. 2023 Nov;70:101832. https://doi.org/10.1016/j.smim.2023.101832

14. Voskarides K, Giannopoulou N. The Role of TP53 in Adaptation and Evolution. Cells. 2023 Feb 3;12(3):512. https://doi.org/10.3390/cells12030512

15. Hao Q, Chen J, Lu H, Zhou X. The ARTS of p53-dependent mitochondrial apoptosis. J Mol Cell Biol. 2023 Mar 29;14(10):mjac074. https://doi.org/10.1093/jmcb/mjac074

16. Wang H, Nicolay BN, Chick JM, Gao X, Geng Y, Ren H, et al. The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival. Nature. 2017 Jun 15;546(7658):426–430. https://doi.org/10.1038/nature22797


Supplementary files

Review

For citations:


Zlatnik E.Yu., Enin Ya.S., Burov O.N., Bondarenko E.S., Sagakyants A.B., Kutilin D.S., Dzigunova Yu.V., Novikova I.A., Przhedetskiy Yu.V. Cellular, genomic and transcriptomic effects of secondary metabolites of the Hybrid Butterbur on the HeLa cell line. South Russian Journal of Cancer. 2024;5(3):50-63. https://doi.org/10.37748/2686-9039-2024-5-3-5. EDN: KOUKIT

Views: 242


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2686-9039 (Online)